Novartis Oncology Patient Advocacy Grants
Novartis Oncology’s Patient Advocacy department provides grant funding to nonprofit patient-advocacy organizations for programs that enhance patient education, community outreach, fundraising, and policy initiatives across a spectrum of cancer and rare-disease areas.
Eligibility Criteria:
-
501(c)(3), 501(c)(4), or 501(c)(6) nonprofit organization
-
Activities must directly serve patients and fall within Novartis’ therapeutic focus (e.g., breast cancer, GIST, ITP, melanoma, multiple myeloma, neuroendocrine tumours, rare diseases)
-
No grants to individuals, personal travel, equipment purchases, service contracts, or events in lavish venues
Funding Details:
-
Support for patient education materials, community‐based events (walks, runs, galas), health policy efforts, and membership dues
-
Funds cannot cover salaries, operating expenses of institutions, or HCP-focused activities
-
Requires a detailed budget and outcomes measurement plan
Deadline:
Submit at least 60 days before the planned activity. Incomplete or late requests will be declined.
Where to Go for Further Information:
All requests must be submitted via NGCS. No email/fax/mail submissions accepted.
For questions, contact: [email protected]
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023